Infliximab vs Biosimilar Infliximab in Patients With Hidradenitis Suppurativa
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Comparing the Effectiveness and Safety Associated With Infliximab vs Infliximab-abda Therapy for Patients With Hidradenitis Suppurativa
JAMA Dermatol 2021 Apr 07;[EPub Ahead of Print], LL Westerkam, KJ Tackett, CJ SayedFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.